HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

AI-Powered Smart COVID-19 Eyewear Tracks Wearer’s Biometrics to Measure Risk of Contracting Coronavirus

By HospiMedica International staff writers
Posted on 14 Sep 2020
Image: COVID-19 Eyewear (Photo courtesy of IP Venture, Inc.)
Image: COVID-19 Eyewear (Photo courtesy of IP Venture, Inc.)
Scientists have developed smart COVID-19 eyewear that measures the user’s risk of potentially contracting the novel coronavirus and advice subsequent actions.

IP Venture, Inc. (San Jose, CA, USA), together with its affiliate company IngenioSpec, is offering smart COVID-19 eyewear that can track a user’s biometrics - such as heart rate, oxygen level, temperature, activity level, and coughing frequency - and provide alert if someone approaching has a high temperature, or has been infected via available contact-tracing programs. By keeping track of the different factors and based on COVID’s signature, the eyewear can better identify the risk of a person getting the virus and can prompt him to consider self-quarantine and schedule for a test ASAP. Knowing if one is positive even a few days earlier can prove vital in fighting the spread of this pandemic.

For those inflicted with the virus, a digital assistant in the eyewear can provide gentle reminders, such as to regularly hydrate; moral support, such as playing a favorite song; or official recommendations, like how many days the user’s family should remain isolated. Through continual monitoring, the eyewear could contact or suggest contacting medical personnel if the user’s condition worsens. For those with “long haul” COVID-19, the eyewear could keep track of a patient’s long-term biometrics to better understand the virus and hopefully find effective treatment.

Related Links:
IP Venture, Inc.

Gold Member
CPAP Ventilator
Somnus DM18
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more